Palmieri-Bouchan RB, Aguirre-Rodríguez VH, Salinas-Vela LE, Encalada-Díaz MI, Valero-González FS

Language: Spanish
References: 19
Page: 288-292
PDF size: 292.28 Kb.

ABSTRACT

Introduction: Reverse shoulder arthroplasty improves function and pain in patients with glenohumeral osteoarthritis and rotator cuff deficiency. However, it is associated with significant blood loss and postoperative hematoma (PO) formation. Objective: To determine the efficacy of tranexamic acid (ATXM) to decrease perioperative bleeding in patients undergoing primary reverse shoulder arthroplasty. Material and methods: Cohort of 31 patients undergoing reverse primary arthroplasty, in two groups: group A (17 patients) were given 1 g IV of preoperative tranexamic acid and group B (14 patients) to whom it was not administered. Preoperative hemoglobin and hematocrit were recorded and then after 24 hours of surgery, and quantified bleeding in drainage at 24 hours, as well as blood transfusion needs. The changes presented were statistically compared. Results: Demographic data did not show significant differences between the two groups. There is a tendency to reduce bleeding in surgical drainage in patients with ATXM (115.6 ml vs. 162.65 ml p = 0.0768), in the decrease of hemoglobin (2.16 g/dl vs. 2.79 g/dl p = 0.1257) and hematocrit (6.67% vs. 7.95% p = 0.3431). There was a significant reduction in the use of blood products in patients with ATXM (p = 0.0441). Conclusion: There is a tendency to have less PO bleeding in patients undergoing primary reverse arthroplasty with the use of ATXM and a lower PO blood transfusion requirement.

REFERENCES

1. Anthony CA, Westermann RW, Gao Y, Pugely AJ, Wolf BR, Hettrich CM. What are risk factors for 30-day morbidity and transfusion in total shoulder arthroplasty? A review of 1922 cases. Clin Orthop Relat Res. 2015; 473: 2099-105.

2. Spiess BD. Risks of transfusion: outcome focus. Transfusion. 2004; 44(12 Suppl): 4S-14S.

3. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999; 57: 1005-32.

4. Boileau P. Complications and revision of reverse total shoulder arthroplasty. Orthop Traumatol Surg Res. 2016; 102(1 Suppl): S33-43.

5. Duramaz A, Bilgili MG, Bayram B, Ziroğlu N, Edipoğlu E, Öneş HN, et al. The role of intraoperative cell salvage system on blood management in major orthopedic surgeries: a cost-benefit analysis. Eur J Orthop Surg Traumatol. 2018; 28(5): 991-7.

6. Copley LA, Richards BS, Safavi FZ, Newton PO. Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine. 1999; 24: 219-22.

7. Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, et al. Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. Orthop Clin North Am. 2017; 48(2): 109-15.

8. George DA, Sarraf KM, Nwaboku H. Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty. Eur J Orthop Surg Traumatol. 2015; 25: 129-33.

9. Day JS, Lau E, Ong KL, Williams GR, Ramsey ML, Kurtz SM. Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg. 2010; 19: 1115-20.

10. Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am. 2011; 93: 2249-54.

11. Gillespie R, Shishani Y, Joseph S, Streit JJ, Gobezie R. Neer Award 2015: A randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty. J Shoulder Elbow Surg. 2015; 24(11): 1679-84.

12. Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B. Tranexamic acid decreases blood loss after total shoulder arthroplasty. J Shoulder Elbow Surg. 2016; 25: 614-8.

13. Vara AD, Koueiter DM, Pinkas DE, Gowda A, Wiater BP, Wiater JM. Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: a prospective, double-blinded, randomized, controlled trial. J Shoulder Elb Surg. 2017; 26: 1383-9.

14. Pauzenberger L, Domej MA, Heuberer PR, Hexel M, Grieb A, Laky B, et al. The effect of intravenous tranexamic acid on blood loss and early postoperative pain in total shoulder arthroplasty. Bone Joint J. 2017; 99-B(8): 1073-9.

15. Gruson KI, Accousti KJ, Parsons BO, Pillai G, Flatow EL. Transfusion after shoulder arthroplasty: an analysis of rates and risk factors. J Shoulder Elbow Surg. 2009; 18: 225-30.

16. Kuo LT, Hsu WH, Chi CC, Yoo JC. Tranexamic acid in total shoulder arthroplasty and reverse shoulder arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2018; 19(1): 60.

17. Anthony SG, Patterson DC, Cagle PJ Jr, Poeran J, Zubizarreta N, Mazumdar M, et al. Utilization and real-world effectiveness of tranexamic use in shoulder arthroplasty: a population-based study. J Am Acad Orthop Surg. 2019; 27(19): 736-42.

18. Kim SH, Jung WI, Kim YJ, Hwang DH, Choi YE. Effect of tranexamic acid on hematologic values and blood loss in reverse total shoulder arthroplasty. Biomed Res Int. 2017; 2017: 9590803.

19. Abildgaard JT, McLemore R, Hattrup SJ. Tranexamic acid decreases blood loss in total shoulder arthroplasty and reverse total shoulder arthroplasty. J Shoulder Elbow Surg. 2016; 25: 1643-8.